This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 1982.
Company Filing History:
Years Active: 1982
Title: Eberhard Waitun: Innovator in Cephalosporin Development
Introduction
Eberhard Waitun is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporins. His innovative work has led to the creation of a patent that showcases his expertise in this area.
Latest Patents
Eberhard Waitun holds a patent for cephalosporins, specifically those of the formula ##STR1##. In this formula, A can be various substituents such as phenyl, 4-hydroxyphenyl, cyclohexyl, cyclohexene-1-yl, cyclohexa-1,4-diene-1-yl, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, or 3,4-disubstituted phenyl. The substituents may include chlorine, hydroxyl, or methoxy, which can be identical or different from each other. This patent highlights his innovative approach to antibiotic development.
Career Highlights
Eberhard Waitun is associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to focus on advancing medical science through innovative drug development. His contributions have been instrumental in enhancing the efficacy of cephalosporins.
Collaborations
Throughout his career, Eberhard has collaborated with notable colleagues such as Bernd Wetzel and Roland Maier. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Eberhard Waitun's contributions to the development of cephalosporins exemplify his dedication to advancing medical science. His innovative patent and collaboration with esteemed colleagues highlight his significant role in the pharmaceutical industry. His work continues to impact the field positively.